<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05158985</url>
  </required_header>
  <id_info>
    <org_study_id>6786</org_study_id>
    <nct_id>NCT05158985</nct_id>
  </id_info>
  <brief_title>Comparative Study Between Different Duty Cycles of Ultrasound Diclofenac Phonophoresis</brief_title>
  <official_title>Comparative Study Between Different Duty Cycles of Ultrasound Diclofenac Phonophoresis in Management of Chronic Lateral Epicondylitis: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>October 6 University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>October 6 University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lateral epicondylitis is a tendinopathy injury involving the extensor muscles of the forearm.&#xD;
      These muscles originate on the lateral epicondylar region of the distal humerus. the&#xD;
      insertion of the extensor carpi radialis brevis is involved in most cases. Transdermal&#xD;
      administration of an anti-inflammatory drug to specific area is one of the methods that used&#xD;
      to decrease inflammation and increase cell metabolism&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lateral epicondylitis is a soft-tissue lesion of the tendinous origin of the wrist extensor&#xD;
      muscles at their origin on the lateral humeral epicondyle. The extensor carpi radialis brevis&#xD;
      is the area of most pathologic changes. It begins as a microtear of the tendinous origin of&#xD;
      the wrist extensor muscles and results in degeneration and reactive granulation tissue&#xD;
      formation. Activities involving prolonged or repeated gripping, wrist extension, forearm&#xD;
      supination, and pronation cause eventual failure of the affected portion of the tendon. The&#xD;
      mechanical failure of the tendon results in an ensuring tendinitis and symptoms of lateral&#xD;
      epicondylitis. It is aggravated with movements of the wrist, by palpation of the lateral side&#xD;
      of elbow, or by contraction of extensor muscles of the wrist.&#xD;
&#xD;
      There are different treatment methods for lateral epicondylitis. Initially, lateral&#xD;
      epicondylitis has been treated with ice, rest, counterforce tennis brace and/or non-steroidal&#xD;
      anti-inflammatory drugs. But when the condition is not responding to initial treatment&#xD;
      physical therapy is initiated&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue scale for pain intensity measurement</measure>
    <time_frame>4 weeks</time_frame>
    <description>A VAS is usually a horizontal line, 100 mm in length, the scale is most commonly anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot;. The patient marks on the line the point that they feel represents their perception of their current state</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hand grip dynamometer for hand grip measurement</measure>
    <time_frame>4 weeks</time_frame>
    <description>The dynamometer has a dual scale readout which displays isometric grip force from 0-90 kg (0-200 lb). The outer dial registers the result in kg and the inner dial registers the result in lb. It has a peak hold needle which automatically retains the highest reading until the device is reset. The handle easily adjusts to five grip positions from 35-87 mm (1½ - 3¼&quot;) in 13 mm (½&quot;) increments. Always use the wrist strap to prevent the dynamometer from falling on the floor if accidentally dropped</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Undefined</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>diclofenac sodium phonophoresis using continuous ultrasound with a frequency of 1MHz, an intensity of 1.5W/Cm2 for 4 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>diclofenac sodium phonophoresis using pulsed US with 1:1 duty cycle with a frequency of 1MHz, an intensity of 1.5W/Cm2 for 4 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>diclofenac sodium phonophoresis using pulsed US with 1:4 duty cycle with a frequency of 1MHz, an intensity of 1.5W/Cm2 for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exercises only in form of (strengthening, stretching and occupational exercises).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>phonophoresis</intervention_name>
    <description>treatment</description>
    <arm_group_label>group A</arm_group_label>
    <arm_group_label>group B</arm_group_label>
    <arm_group_label>group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>exercises</intervention_name>
    <description>treatment</description>
    <arm_group_label>group D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Both sexes will be involved&#xD;
&#xD;
          2. Duration of the disease is more than 12 weeks.&#xD;
&#xD;
          3. Patient's age ranges from 20 to 40 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diabetic patients.&#xD;
&#xD;
          2. Hypertension patients.&#xD;
&#xD;
          3. Pregnant women&#xD;
&#xD;
          4. Cardiovascular patients&#xD;
&#xD;
          5. Patients with malunion fractures&#xD;
&#xD;
          6. Patients with cervical Radiclopathy&#xD;
&#xD;
          7. Patients with olecranon bursitis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Emad MOHAMED</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emad MOHAMED</last_name>
      <phone>01146808839</phone>
      <email>Omdamohamed9111@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 18, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 15, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>October 6 University</investigator_affiliation>
    <investigator_full_name>basma osama</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

